PLA2R-Negative Membranous Nephropathy Presenting as a Prodrome of IgG4-Related Autoimmune Pancreatitis

Case Reports in Nephrology and Dialysis
Magdalini VelegrakiAngeliki Theodoropoulou

Abstract

Membranous nephropathy (MN) with tubulointerstitial nephritis (TIN) is an established manifestation of immunoglobulin G4 (IgG4)-related disease (IgG4-RD). A pathological feature aiming to distinguish between primary and secondary MN is the presence or absence of glomerular staining for phospholipase A2 receptor (PLA2R), respectively. Isolated MN without TIN has been rarely reported in the context of IgG4-RD. This case report describes a patient with a history of MN successfully treated with steroids and cyclophosphamide, who, 3 years later, presented with unexplained exacerbation of diabetes mellitus due to IgG4-related autoimmune pancreatitis. Pancreatitis was treated, and diabetes improved after treatment with steroids. Based on the presence of isolated IgG4 glomerular capillary deposits along with negative staining for PLA2R and the metachronous appearance of autoimmune pancreatitis, MN was retrospectively classified as secondary to IgG4-RD. Isolated IgG4-positive/PLA2R-negative MN without TIN can be a prodrome of IgG4-RD, reminiscent of MN secondary to neoplasms.

References

Jan 23, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Shin-ichi TakedaEisuke Takazakura
Dec 22, 2006·The New England Journal of Medicine·Dmitry L FinkelbergWilliam R Brugge
Sep 27, 2007·The American Journal of Surgical Pathology·Lynn D CornellRobert B Colvin
Feb 27, 2009·Gastrointestinal Endoscopy·Marc F CatalanoLyndon V Hernandez
May 5, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Suresh T ChariSanthi S Vege
Jul 3, 2010·The Journal of Rheumatology·George E Fragoulis, Haralampos M Moutsopoulos
Jun 11, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paolo CravediGiuseppe Remuzzi
May 19, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Vikram DeshpandeJohn H Stone
Dec 21, 2012·Kidney International·Mariam P AlexanderLynn D Cornell
Jan 19, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Cheng Cheng HuangTibor Nadasdy
May 24, 2013·Kidney International·Takako SaekiIchiei Narita
Oct 12, 2013·Annual Review of Pathology·Vinay S MahajanJohn H Stone
Mar 19, 2014·Journal of Gastroenterology·Kazuichi OkazakiUNKNOWN Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by t
Mar 19, 2014·Journal of Gastroenterology·Terumi KamisawaUNKNOWN Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by t
Mar 31, 2015·Pancreas·Atsushi KannoUNKNOWN Research Committee of Intractable Diseases of the Pancreas
Apr 8, 2015·Case Reports in Nephrology and Dialysis·Kostas StylianouEugene Daphnis
Jul 1, 2015·Nature Reviews. Nephrology·Frank B Cortazar, John H Stone
Oct 16, 2016·Clinical Nephrology·Mercedes Acevedo RibóEugenio García Diaz

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

© 2021 Meta ULC. All rights reserved